Med Spa DSCSA Compliance
Using GLP-1s or Injectables in Your Med Spa? – Then DSCSA Apply to You!
The Drug Supply Chain Security Act (DSCSA) is an FDA-enforced law requiring med spas handling products like Botox, fillers, and GLP-1s to verify suppliers, track products, and maintain audit-ready records. If you buy, store, or administer these products — you are part of the regulated supply chain.
Increased FDA inspections is actively affecting Medical Spas making DSCSA compliance mandatory and failure to comply can result in fines, license suspension, and even criminal liability. If you can’t verify your products and suppliers instantly, your business is at risk.
Where Most Med Spas Fall Short- Buying from unverified or “discount” suppliers
- No system to track product origin
- Paper logs or incomplete records
- No way to respond quickly to inspections
How InfiniTrak Simplifies Compliance
Running a med spa is already complex — compliance shouldn’t be.
InfiniTrak simplifies DSCSA and FDA requirements by giving you one easy-to-use platform at best price to verify your suppliers, track every product, and keep your records organized and audit-ready.
InfiniTrak Enables:
- Authorized supplier verification — know exactly where your products come from
- End-to-end product traceability — from manufacturer to patient
- Real-time product verification — validate NDC, lot, expiration, and serial
- Audit-ready recordkeeping — maintain secure, compliant records
- Suspect product management — quickly identify and handle risks
- EPCIS data support — meet DSCSA data exchange requirements
Med Spa DSCSA News
Med Spa May Soon Face Pharmacy Level Oversight: Iowa’s New Bill Could Redefine Compliance
Med Spa May Soon Face Pharmacy Level Oversight: Iowa’s New Bill Could Redefine Compliance The medical spa industry has grown at an extraordinary pace approaching
Nearly 40% of New York Med Spas Cited
40% of New York Med Spas Failed DSCSA Inspections: Med Spa Compliance Warning Med spa treatments have exploded in popularity over the past few years.
FDA Targets DSCSA Violations in 2026 | News Alert
FDA Steps Up DSCSA Inspections in 2026: What Dispensers and Pharmacies Must Know The FDA recently made headlines with its first publicly documented Drug Supply